Metronidazole reduces intestinal inflammation and blood loss in non-steroidal anti-inflammatory drug induced enteropathy

175Citations
Citations of this article
38Readers
Mendeley users who have this article in their library.

Abstract

This study assessed the effect of metronidazole on the gastroduodenal mucosa, intestinal permeability, blood loss, and inflammation in patients on non-steroidal anti-inflammatory drugs (NSAIDs). Thirteen patients were studied before and after 2-12 weeks' treatment with metronidazole 800 mg/day, while maintaining an unchanged NSAID intake. Intestinal inflammation, as assessed by the faecal excretion of indium-ill labelled neutrophils, and blood loss, assessed with chromium- 51 labelled red cells, were significantly reduced after treatment (mean (SD) 111In excretion 4.7 (4.7)% v 1.5 (1.3)% (N<1 0%), p<0.001, 51Cr red cells loss 2.6 (1.6) ml/day v 0.9 (0.5) ml/day (N<1.0 mllday), p<001). Intestinal permeability assessed as the 5 hour urinary excretion ratio of 51CrEDTAIL-rhamnose did not change significantly (0.133 (0.046) v 0.154 (0.064), p>0 1) and there were no significant changes in the endoscopic or microscopic appearances of the gastroduodenal mucosa. These results suggest that the neutrophil is the main damaging effector cell in NSAID induced enteropathy. The main neutrophil chemo-attractant in this enteropathy may be a metronidazole sensitive microbe.

Cite

CITATION STYLE

APA

Bjarnason, I., Hayllar, J., Smethurst, P., Price, A., & Gumpel, M. J. (1992). Metronidazole reduces intestinal inflammation and blood loss in non-steroidal anti-inflammatory drug induced enteropathy. Gut, 33(9), 1204–1208. https://doi.org/10.1136/gut.33.9.1204

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free